Synairgen PLC (GB:SNG)
LSE:SNG
Holding GB:SNG?
Track your performance easily

Synairgen (SNG) Income Statement

15 Followers

Synairgen Income Statement

Last quarter (Q2 2022), Synairgen's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, Synairgen's net income was £―. See Synairgen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---£ 0.00£ 0.00£ 105.00K
Cost of Revenue
------
Gross Profit
------
Operating Expense
-£ 20.30M£ 57.87M£ 17.74M£ 4.82M£ 4.24M
Operating Income
-£ -20.30M£ -57.87M£ -17.74M£ -4.82M£ -4.13M
Net Non Operating Interest Income Expense
-£ 207.00K£ -9.00K£ 9.00K£ 24.00K£ 36.00K
Other Income Expense
------
Pretax Income
-£ -20.09M£ -57.86M£ -17.73M£ -4.79M£ -4.10M
Tax Provision
-£ -2.45M£ -9.19M£ -3.82M£ -908.00K£ -795.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -17.64M£ -48.66M£ -13.92M£ -3.88M£ -3.30M
Basic EPS
-£ -0.09£ -0.24£ -0.09£ -0.04£ -0.03
Diluted EPS
-£ -0.09£ -0.24£ -0.09£ -0.04£ -0.03
Basic Average Shares
-£ 201.36M£ 200.44M£ 147.12M£ 110.09M£ 95.83M
Diluted Average Shares
-£ 201.36M£ 200.44M£ 147.12M£ 110.09M£ 95.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---£ 0.00£ 96.00K£ 165.00K
Total Expenses
-£ 20.30M£ -57.87M£ 17.74M£ 4.82M£ 4.24M
Net Income From Continuing And Discontinued Operation
-£ -17.64M£ -48.66M£ -13.92M£ -3.88M£ -3.30M
Normalized Income
-£ -22.54M£ -67.05M£ -13.92M£ -3.88M£ -3.30M
Interest Expense
---£ 10.00K£ 6.00K-
EBIT
-£ -20.09M£ -57.85M£ -17.72M£ -4.79M£ -4.13M
EBITDA
-£ -19.99M£ -57.85M£ -17.46M£ -4.62M£ -4.09M
Currency in GBP

Synairgen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis